Viewing StudyNCT00044759



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00044759
Status: COMPLETED
Last Update Posted: 2007-10-10
First Post: 2002-09-04

Brief Title: Study Comparing the Safety and Efficacy of PiperacillinTazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization: Wyeth is now a wholly owned subsidiary of Pfizer

Organization Data

Organization: Wyeth is now a wholly owned subsidiary of Pfizer
Class: INDUSTRY
Study ID: 0910B1-308
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators